Deepti A. Chopra, MBBS

Dr Chopra is affiliated with the University of Texas MD Anderson Cancer Center in Houston, Texas.

Articles by Deepti A. Chopra, MBBS

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

ByGregg A. Robbins-Welty, MD, MS,Andrew N. Tuck, MD,Dale Marchant, FRANZCP,Andrew Gleason, FRANZCP,Richard Garrett Key, MD,Barbara Lubrano Di Ciccone, MD,Deepti A. Chopra, MBBS,Mona Mojtahedzadeh, MD,Fíona Fonseca, MD,Hermioni Lokko Amonoo, MD,Andrea DeSimone, DO,Daniel C. McFarland, DO

October 27th 2023

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

ByGregg A. Robbins-Welty, MD, MS,Andrew N. Tuck, MD,Dale Marchant, FRANZCP,Andrew Gleason, FRANZCP,Richard Garrett Key, MD,Barbara Lubrano Di Ciccone, MD,Deepti A. Chopra, MBBS,Mona Mojtahedzadeh, MD,Fíona Fonseca, MD,Hermioni Lokko Amonoo, MD,Andrea DeSimone, DO,Daniel C. McFarland, DO

September 26th 2023

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

Deepti A. Chopra, MBBS

Articles by Deepti A. Chopra, MBBS

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

Latest Updated Articles